Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy

Nature Biotechnology (Impact Factor: 39.08). 12/2004; 23(2):222-226. DOI: 10.1038/nbt1051
Source: PubMed

ABSTRACT RNA interference (RNAi) is the process of sequence-specific post-transcriptional gene silencing triggered by double-stranded RNAs

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: RNAi-based nucleic acid molecules have attracted considerable attention as compelling therapeutics providing safe and competent delivery systems are available. Dendrimers are emerging as appealing nanocarriers for nucleic acid delivery thanks to their unique well-defined architecture and the resulting cooperativity and multivalency confined within a nanostructure. The present review offers a brief overview of the structurally flexible triethanolamine-core poly(amidoamine) (PAMAM) dendrimers developed in our group as nanovectors for the delivery of RNAi therapeutics. Their excellent activity for delivering different RNAi therapeutics in various disease models in vitro and in vivo will be highlighted here.
    Biotechnology advances 08/2013; DOI:10.1016/j.biotechadv.2013.08.001 · 8.91 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Soon after discovery of RNA interference (RNAi), its potential as eff ective antiviral therapy was recognized. Since then RNAi has been variously exploited for antiviral purposes which could eff ectively block viral replication in vitro. For in vivo use, however, delivery issue, toxicity, RNAi suppression and viral escape are still major hurdles. Here, we provide an overview of the RNAi strategy and review the approaches that have been developed to surpass the obstacles and to achieve targeted gene silencing for antiviral and other therapies.
    01/2013; 18(1-2):1-23. DOI:10.17525/vrr.v18i1-2.92
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The RNAimmuno database was created to provide easy access to information regarding the nonspecific effects generated in cells by RNA interference triggers and microRNA regulators. Various RNAi and microRNA reagents, which differ in length and structure, often cause non-sequence-specific immune responses, in addition to triggering the intended sequence-specific effects. The activation of the cellular sensors of foreign RNA or DNA may lead to the induction of type I interferon and proinflammatory cytokine release. Subsequent changes in the cellular transcriptome and proteome may result in adverse effects, including cell death during therapeutic treatments or the misinterpretation of experimental results in research applications. The manually curated RNAimmuno database gathers the majority of the published data regarding the immunological side effects that are caused in investigated cell lines, tissues, and model organisms by different reagents. The database is accessible at and may be helpful in the further application and development of RNAi- and microRNA-based technologies.
    RNA 03/2012; 18(5):930-5. DOI:10.1261/rna.025627.110 · 4.62 Impact Factor

Preview (2 Sources)

Available from